1x26: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1x26]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1X26 FirstGlance]. <br> | <table><tr><td colspan='2'>[[1x26]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1X26 FirstGlance]. <br> | ||
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAZ:N~3~-{3-[(7-METHYL-1,8-NAPHTHYRIDIN-2-YL)AMINO]-3-OXOPROPYL}-N~1~-[(7-OXO-7,8-DIHYDRO-1,8-NAPHTHYRIDIN-2-YL)METHYL]-BETA-ALANINAMIDE'>NAZ</scene>< | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAZ:N~3~-{3-[(7-METHYL-1,8-NAPHTHYRIDIN-2-YL)AMINO]-3-OXOPROPYL}-N~1~-[(7-OXO-7,8-DIHYDRO-1,8-NAPHTHYRIDIN-2-YL)METHYL]-BETA-ALANINAMIDE'>NAZ</scene></td></tr> | ||
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1x26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1x26 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1x26 RCSB], [http://www.ebi.ac.uk/pdbsum/1x26 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1x26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1x26 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1x26 RCSB], [http://www.ebi.ac.uk/pdbsum/1x26 PDBsum]</span></td></tr> | ||
<table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 18: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Goto, Y | [[Category: Goto, Y]] | ||
[[Category: Hagihara, M | [[Category: Hagihara, M]] | ||
[[Category: Hagihara, S | [[Category: Hagihara, S]] | ||
[[Category: Hayashi, G | [[Category: Hayashi, G]] | ||
[[Category: Kobori, A | [[Category: Kobori, A]] | ||
[[Category: Kojima, C | [[Category: Kojima, C]] | ||
[[Category: Kyo, M | [[Category: Kyo, M]] | ||
[[Category: Mishima, M | [[Category: Mishima, M]] | ||
[[Category: Nakatani, K | [[Category: Nakatani, K]] | ||
[[Category: Nomura, M | [[Category: Nomura, M]] | ||
[[Category: Aa mismatch]] | [[Category: Aa mismatch]] | ||
[[Category: Dna]] | [[Category: Dna]] | ||
[[Category: Drug]] | [[Category: Drug]] | ||
Revision as of 22:26, 3 January 2015
Solution structure of the AA-mismatch DNA complexed with naphthyridine-azaquinolone
| ||||||||||||
